 | • レポートコード：MRC2-11QY11072 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は生物学的製品製造のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、組換えタンパク質、成長ホルモン、ベータインターフェロン、治療用酵素）市場規模、用途別（病院、専門クリニック、政府研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別生物学的製品製造の競争状況、市場シェア ・世界の生物学的製品製造市場：種類別市場規模 2015年-2020年（モノクローナル抗体、組換えタンパク質、成長ホルモン、ベータインターフェロン、治療用酵素） ・世界の生物学的製品製造市場：種類別市場規模予測 2021年-2026年（モノクローナル抗体、組換えタンパク質、成長ホルモン、ベータインターフェロン、治療用酵素） ・世界の生物学的製品製造市場：用途別市場規模 2015年-2020年（病院、専門クリニック、政府研究所） ・世界の生物学的製品製造市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック、政府研究所） ・北米の生物学的製品製造市場分析：米国、カナダ ・ヨーロッパの生物学的製品製造市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの生物学的製品製造市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の生物学的製品製造市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの生物学的製品製造市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、F.Hoffmann-La Roche、Merck、Bayer、Lonza、China Biologic Products、Pfizer、Sanofi、Teva Pharmaceutical Industries、Amgen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The biological product manufacturing is a complex process which produces products derived from recombinant DNA technology to develop a series of processes to manufacture therapeutic products. A biological product can be a virus, antitoxin, vaccine, blood component or derivative, allergenic product, or analogous product, or any therapeutic serum used for the treatment of a disease in humans. These biological products were developed from multicellular systems comprising of plants, animals, unicellular organisms and a mammalian cell. Biological products are composed of sugars, nucleic acids or combination of both.
The biological products are produced in three ways: by developing ways to achieve commercial production of the substance to be used, by gene alteration of the molecule and finally by developing an entirely new substance. Some of the tools used by modern day researcher in the manufacturing of biological products are recombinant DNA and monoclonal antibodies. Recombinant DNA involves altering of the DNA chain of one organism with desired DNA molecule to produce a novel biological product. Monoclonal antibodies were developed from single cell cultures using cloning techniques; these were designed to fight against toxins, viruses, and cancer cells. The first genetically engineered biological product approved for use in the U.S. was a vaccine for hepatitis-B which was approved in 1986, in the same year, other biological products like therapeutic monoclonal antibodies (MAB’s) and alpha interferon’s were approved.
Market Analysis and Insights: Global Biological Product Manufacturing Market
The global Biological Product Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Biological Product Manufacturing Scope and Market Size
Biological Product Manufacturing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biological Product Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novartis
F.Hoffmann-La Roche
Merck
Bayer
Lonza
China Biologic Products
Pfizer
Sanofi
Teva Pharmaceutical Industries
Amgen
Market segment by Type, the product can be split into
Monoclonal Antibodies
Recombinant Proteins
Growth Hormones
Beta Interferon
Therapeutic Enzymes
Market segment by Application, split into
Hospitals
Specialized Clinics
Government Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biological Product Manufacturing Revenue
1.4 Market by Type
1.4.1 Global Biological Product Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Recombinant Proteins
1.4.4 Growth Hormones
1.4.5 Beta Interferon
1.4.6 Therapeutic Enzymes
1.5 Market by Application
1.5.1 Global Biological Product Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialized Clinics
1.5.4 Government Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Biological Product Manufacturing Market Perspective (2015-2026)
2.2 Global Biological Product Manufacturing Growth Trends by Regions
2.2.1 Biological Product Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biological Product Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Biological Product Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biological Product Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Biological Product Manufacturing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biological Product Manufacturing Players by Market Size
3.1.1 Global Top Biological Product Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Biological Product Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Biological Product Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biological Product Manufacturing Market Concentration Ratio
3.2.1 Global Biological Product Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biological Product Manufacturing Revenue in 2019
3.3 Biological Product Manufacturing Key Players Head office and Area Served
3.4 Key Players Biological Product Manufacturing Product Solution and Service
3.5 Date of Enter into Biological Product Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biological Product Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Biological Product Manufacturing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Biological Product Manufacturing Market Size by Application (2015-2020)
5.2 Global Biological Product Manufacturing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biological Product Manufacturing Market Size (2015-2020)
6.2 Biological Product Manufacturing Key Players in North America (2019-2020)
6.3 North America Biological Product Manufacturing Market Size by Type (2015-2020)
6.4 North America Biological Product Manufacturing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biological Product Manufacturing Market Size (2015-2020)
7.2 Biological Product Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Biological Product Manufacturing Market Size by Type (2015-2020)
7.4 Europe Biological Product Manufacturing Market Size by Application (2015-2020)
8 China
8.1 China Biological Product Manufacturing Market Size (2015-2020)
8.2 Biological Product Manufacturing Key Players in China (2019-2020)
8.3 China Biological Product Manufacturing Market Size by Type (2015-2020)
8.4 China Biological Product Manufacturing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biological Product Manufacturing Market Size (2015-2020)
9.2 Biological Product Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Biological Product Manufacturing Market Size by Type (2015-2020)
9.4 Japan Biological Product Manufacturing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biological Product Manufacturing Market Size (2015-2020)
10.2 Biological Product Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biological Product Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Biological Product Manufacturing Market Size by Application (2015-2020)
11 India
11.1 India Biological Product Manufacturing Market Size (2015-2020)
11.2 Biological Product Manufacturing Key Players in India (2019-2020)
11.3 India Biological Product Manufacturing Market Size by Type (2015-2020)
11.4 India Biological Product Manufacturing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biological Product Manufacturing Market Size (2015-2020)
12.2 Biological Product Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Biological Product Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Biological Product Manufacturing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Biological Product Manufacturing Introduction
13.1.4 Novartis Revenue in Biological Product Manufacturing Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 F.Hoffmann-La Roche
13.2.1 F.Hoffmann-La Roche Company Details
13.2.2 F.Hoffmann-La Roche Business Overview
13.2.3 F.Hoffmann-La Roche Biological Product Manufacturing Introduction
13.2.4 F.Hoffmann-La Roche Revenue in Biological Product Manufacturing Business (2015-2020)
13.2.5 F.Hoffmann-La Roche Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Biological Product Manufacturing Introduction
13.3.4 Merck Revenue in Biological Product Manufacturing Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Bayer
13.4.1 Bayer Company Details
13.4.2 Bayer Business Overview
13.4.3 Bayer Biological Product Manufacturing Introduction
13.4.4 Bayer Revenue in Biological Product Manufacturing Business (2015-2020)
13.4.5 Bayer Recent Development
13.5 Lonza
13.5.1 Lonza Company Details
13.5.2 Lonza Business Overview
13.5.3 Lonza Biological Product Manufacturing Introduction
13.5.4 Lonza Revenue in Biological Product Manufacturing Business (2015-2020)
13.5.5 Lonza Recent Development
13.6 China Biologic Products
13.6.1 China Biologic Products Company Details
13.6.2 China Biologic Products Business Overview
13.6.3 China Biologic Products Biological Product Manufacturing Introduction
13.6.4 China Biologic Products Revenue in Biological Product Manufacturing Business (2015-2020)
13.6.5 China Biologic Products Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Biological Product Manufacturing Introduction
13.7.4 Pfizer Revenue in Biological Product Manufacturing Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview
13.8.3 Sanofi Biological Product Manufacturing Introduction
13.8.4 Sanofi Revenue in Biological Product Manufacturing Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Teva Pharmaceutical Industries
13.9.1 Teva Pharmaceutical Industries Company Details
13.9.2 Teva Pharmaceutical Industries Business Overview
13.9.3 Teva Pharmaceutical Industries Biological Product Manufacturing Introduction
13.9.4 Teva Pharmaceutical Industries Revenue in Biological Product Manufacturing Business (2015-2020)
13.9.5 Teva Pharmaceutical Industries Recent Development
13.10 Amgen
13.10.1 Amgen Company Details
13.10.2 Amgen Business Overview
13.10.3 Amgen Biological Product Manufacturing Introduction
13.10.4 Amgen Revenue in Biological Product Manufacturing Business (2015-2020)
13.10.5 Amgen Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Biological Product Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Biological Product Manufacturing Revenue
Table 3. Ranking of Global Top Biological Product Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biological Product Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Recombinant Proteins
Table 7. Key Players of Growth Hormones
Table 8. Key Players of Beta Interferon
Table 9. Key Players of Therapeutic Enzymes
Table 10. Global Biological Product Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Biological Product Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Biological Product Manufacturing Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Biological Product Manufacturing Market Share by Regions (2015-2020)
Table 14. Global Biological Product Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Biological Product Manufacturing Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Biological Product Manufacturing Market Growth Strategy
Table 20. Main Points Interviewed from Key Biological Product Manufacturing Players
Table 21. Global Biological Product Manufacturing Revenue by Players (2015-2020) (Million US$)
Table 22. Global Biological Product Manufacturing Market Share by Players (2015-2020)
Table 23. Global Top Biological Product Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biological Product Manufacturing as of 2019)
Table 24. Global Biological Product Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Biological Product Manufacturing Product Solution and Service
Table 27. Date of Enter into Biological Product Manufacturing Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biological Product Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 30. Global Biological Product Manufacturing Market Size Share by Type (2015-2020)
Table 31. Global Biological Product Manufacturing Revenue Market Share by Type (2021-2026)
Table 32. Global Biological Product Manufacturing Market Size Share by Application (2015-2020)
Table 33. Global Biological Product Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 34. Global Biological Product Manufacturing Market Size Share by Application (2021-2026)
Table 35. North America Key Players Biological Product Manufacturing Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Biological Product Manufacturing Market Share (2019-2020)
Table 37. North America Biological Product Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 38. North America Biological Product Manufacturing Market Share by Type (2015-2020)
Table 39. North America Biological Product Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 40. North America Biological Product Manufacturing Market Share by Application (2015-2020)
Table 41. Europe Key Players Biological Product Manufacturing Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Biological Product Manufacturing Market Share (2019-2020)
Table 43. Europe Biological Product Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Biological Product Manufacturing Market Share by Type (2015-2020)
Table 45. Europe Biological Product Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Biological Product Manufacturing Market Share by Application (2015-2020)
Table 47. China Key Players Biological Product Manufacturing Revenue (2019-2020) (Million US$)
Table 48. China Key Players Biological Product Manufacturing Market Share (2019-2020)
Table 49. China Biological Product Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 50. China Biological Product Manufacturing Market Share by Type (2015-2020)
Table 51. China Biological Product Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 52. China Biological Product Manufacturing Market Share by Application (2015-2020)
Table 53. Japan Key Players Biological Product Manufacturing Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Biological Product Manufacturing Market Share (2019-2020)
Table 55. Japan Biological Product Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Biological Product Manufacturing Market Share by Type (2015-2020)
Table 57. Japan Biological Product Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Biological Product Manufacturing Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Biological Product Manufacturing Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Biological Product Manufacturing Market Share (2019-2020)
Table 61. Southeast Asia Biological Product Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Biological Product Manufacturing Market Share by Type (2015-2020)
Table 63. Southeast Asia Biological Product Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Biological Product Manufacturing Market Share by Application (2015-2020)
Table 65. India Key Players Biological Product Manufacturing Revenue (2019-2020) (Million US$)
Table 66. India Key Players Biological Product Manufacturing Market Share (2019-2020)
Table 67. India Biological Product Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 68. India Biological Product Manufacturing Market Share by Type (2015-2020)
Table 69. India Biological Product Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 70. India Biological Product Manufacturing Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Biological Product Manufacturing Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Biological Product Manufacturing Market Share (2019-2020)
Table 73. Central & South America Biological Product Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Biological Product Manufacturing Market Share by Type (2015-2020)
Table 75. Central & South America Biological Product Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Biological Product Manufacturing Market Share by Application (2015-2020)
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Product
Table 80. Novartis Revenue in Biological Product Manufacturing Business (2015-2020) (Million US$)
Table 81. Novartis Recent Development
Table 82. F.Hoffmann-La Roche Company Details
Table 83. F.Hoffmann-La Roche Business Overview
Table 84. F.Hoffmann-La Roche Product
Table 85. F.Hoffmann-La Roche Revenue in Biological Product Manufacturing Business (2015-2020) (Million US$)
Table 86. F.Hoffmann-La Roche Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Product
Table 90. Merck Revenue in Biological Product Manufacturing Business (2015-2020) (Million US$)
Table 91. Merck Recent Development
Table 92. Bayer Company Details
Table 93. Bayer Business Overview
Table 94. Bayer Product
Table 95. Bayer Revenue in Biological Product Manufacturing Business (2015-2020) (Million US$)
Table 96. Bayer Recent Development
Table 97. Lonza Company Details
Table 98. Lonza Business Overview
Table 99. Lonza Product
Table 100. Lonza Revenue in Biological Product Manufacturing Business (2015-2020) (Million US$)
Table 101. Lonza Recent Development
Table 102. China Biologic Products Company Details
Table 103. China Biologic Products Business Overview
Table 104. China Biologic Products Product
Table 105. China Biologic Products Revenue in Biological Product Manufacturing Business (2015-2020) (Million US$)
Table 106. China Biologic Products Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Business Overview
Table 109. Pfizer Product
Table 110. Pfizer Revenue in Biological Product Manufacturing Business (2015-2020) (Million US$)
Table 111. Pfizer Recent Development
Table 112. Sanofi Business Overview
Table 113. Sanofi Product
Table 114. Sanofi Company Details
Table 115. Sanofi Revenue in Biological Product Manufacturing Business (2015-2020) (Million US$)
Table 116. Sanofi Recent Development
Table 117. Teva Pharmaceutical Industries Company Details
Table 118. Teva Pharmaceutical Industries Business Overview
Table 119. Teva Pharmaceutical Industries Product
Table 120. Teva Pharmaceutical Industries Revenue in Biological Product Manufacturing Business (2015-2020) (Million US$)
Table 121. Teva Pharmaceutical Industries Recent Development
Table 122. Amgen Company Details
Table 123. Amgen Business Overview
Table 124. Amgen Product
Table 125. Amgen Revenue in Biological Product Manufacturing Business (2015-2020) (Million US$)
Table 126. Amgen Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biological Product Manufacturing Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Recombinant Proteins Features
Figure 4. Growth Hormones Features
Figure 5. Beta Interferon Features
Figure 6. Therapeutic Enzymes Features
Figure 7. Global Biological Product Manufacturing Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Specialized Clinics Case Studies
Figure 10. Government Research Institutes Case Studies
Figure 11. Biological Product Manufacturing Report Years Considered
Figure 12. Global Biological Product Manufacturing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Biological Product Manufacturing Market Share by Regions: 2020 VS 2026
Figure 14. Global Biological Product Manufacturing Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Biological Product Manufacturing Market Share by Players in 2019
Figure 17. Global Top Biological Product Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biological Product Manufacturing as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Biological Product Manufacturing Revenue in 2019
Figure 19. North America Biological Product Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Biological Product Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Biological Product Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Biological Product Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Biological Product Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Biological Product Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Biological Product Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…- 組換えタンパク質の世界市場（～2026年） Market Analysis and Insights: Global Recombinant Protein Market The global Recombinant Protein market size is projected to reach US$ 665.5 million by 2026, from US$ 612 million in 2020, at a CAGR of 8.1%% during 2021-2026. Global Recombinant Protein Scope and Market Size Recombinant Protein market i…
- 生物学的安全性試験の世界市場（～2026年） Biological safety testing is carried out to ensure non-contamination of biopharmaceuticals and vaccines and to comply with regulations regarding the same. It is a major step towards the launch of innovative biopharmaceutical products. Biological safety testing is essential to ensure product safety, …
- 生物製剤の世界市場（～2026年） The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have h…
- モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…